Clinical Trial Update: Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating feasibility of at-home instillation of UGN-102 for low-grade non-muscle invasive bladder cancer. Results were posted in Septembe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer
• Urothelial Carcinoma
• Urothelial Carcinoma of the Bladder

Drugs mentioned

• UGN-102 (UGN-102)

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Bladder Cancer, Urothelial Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19